{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:12:53Z","timestamp":1780791173834,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-15863-3","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T17:44:30Z","timestamp":1755711870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cholesterol-modulating effects of Korean red ginseng (KRG) targeting PCSK9 in hyperlipidemia"],"prefix":"10.1038","volume":"15","author":[{"given":"Chang Hwan","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Yook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Sun","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Hee","family":"Hyun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaehoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hye","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Kyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"15863_CR1","doi-asserted-by":"publisher","first-page":"e16412","DOI":"10.7759\/cureus.16412","volume":"13","author":"KJ Ezeh","year":"2021","unstructured":"Ezeh, K. J., Ezeudemba, O. & Hyperlipidemia A review of the novel methods for the management of lipids. Cureus 13, e16412. https:\/\/doi.org\/10.7759\/cureus.16412 (2021).","journal-title":"Cureus"},{"key":"15863_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pop.2012.11.003","volume":"40","author":"RH Nelson","year":"2013","unstructured":"Nelson, R. H. Hyperlipidemia as a risk factor for cardiovascular disease. Prim. Care. 40, 195\u2013211. https:\/\/doi.org\/10.1016\/j.pop.2012.11.003 (2013).","journal-title":"Prim. Care"},{"key":"15863_CR3","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.jacc.2022.11.001","volume":"80","author":"M Lindstrom","year":"2022","unstructured":"Lindstrom, M. et al. Global burden of cardiovascular diseases and risks collaboration, 1990\u20132021. J. Am. Coll. Cardiol. 80, 2372\u20132425. https:\/\/doi.org\/10.1016\/j.jacc.2022.11.001 (2022).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"Suppl 1","key":"15863_CR4","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1016\/j.ihj.2023.12.011","volume":"76","author":"T Nair","year":"2024","unstructured":"Nair, T. Role of PCSK9 inhibitors in the management of dyslipidaemia. Indian Heart J. 76 (Suppl 1), S44\u2013S50. https:\/\/doi.org\/10.1016\/j.ihj.2023.12.011 (2024).","journal-title":"Indian Heart J."},{"key":"15863_CR5","doi-asserted-by":"publisher","first-page":"18602","DOI":"10.1074\/jbc.M702027200","volume":"282","author":"DW Zhang","year":"2007","unstructured":"Zhang, D. W. et al. Binding of proprotein convertase subtilisin\/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation. J. Biol. Chem. 282, 18602\u201318612. https:\/\/doi.org\/10.1074\/jbc.M702027200 (2007).","journal-title":"J. Biol. Chem."},{"key":"15863_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.abb.2017.06.001","volume":"625\u2013626","author":"QM Melendez","year":"2017","unstructured":"Melendez, Q. M., Krishnaji, S. T., Wooten, C. J., Lopez, D. & Hypercholesterolemia The role of PCSK9. Arch. Biochem. Biophys. 625\u2013626, 39\u201353. https:\/\/doi.org\/10.1016\/j.abb.2017.06.001 (2017).","journal-title":"Arch. Biochem. Biophys."},{"key":"15863_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11883-016-0604-3","volume":"18","author":"BA Taylor","year":"2016","unstructured":"Taylor, B. A. & Thompson, P. D. Statins and their effect on PCSK9-impact and clinical relevance. Curr. Atheroscler Rep. 18, 46. https:\/\/doi.org\/10.1007\/s11883-016-0604-3 (2016).","journal-title":"Curr. Atheroscler Rep."},{"key":"15863_CR8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","volume":"19","author":"E Bruckert","year":"2005","unstructured":"Bruckert, E., Hayem, G., Dejager, S., Yau, C. & B\u00e9gaud, B. Mild to moderate muscular symptoms with high-dosage Statin therapy in hyperlipidemic patients\u2014the PRIMO study. Cardiovasc. Drugs Ther. 19, 403\u2013414. https:\/\/doi.org\/10.1007\/s10557-005-5686-z (2005).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"15863_CR9","doi-asserted-by":"publisher","first-page":"173114","DOI":"10.1016\/j.ejphar.2020.173114","volume":"878","author":"E Gallego-Colon","year":"2020","unstructured":"Gallego-Colon, E., Daum, A., Yosefy, C. & Statins PCSK9 inhibitors: A new lipid-lowering therapy. Eur. J. Pharmacol. 878, 173114. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173114 (2020).","journal-title":"Eur. J. Pharmacol."},{"key":"15863_CR10","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/nbt0815-785","volume":"33","author":"C Sheridan","year":"2015","unstructured":"Sheridan, C. New class PCSK9 blockers Stride into cholesterol market. Nat. Biotechnol. 33, 785\u2013786. https:\/\/doi.org\/10.1038\/nbt0815-785 (2015).","journal-title":"Nat. Biotechnol."},{"key":"15863_CR11","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ymthe.2018.10.016","volume":"27","author":"M Khoshnejad","year":"2019","unstructured":"Khoshnejad, M. et al. Development of novel DNA-encoded PCSK9 monoclonal antibodies as lipid-lowering therapeutics. Mol. Ther. 27, 188\u2013199. https:\/\/doi.org\/10.1016\/j.ymthe.2018.10.016 (2019).","journal-title":"Mol. Ther."},{"key":"15863_CR12","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/j.1745-7254.2008.00868.x","volume":"29","author":"CF Chen","year":"2008","unstructured":"Chen, C. F., Chiou, W. F. & Zhang, J. T. Comparison of the Pharmacological effects of Panax ginseng and Panax quinquefolium. Acta Pharmacol. Sin. 29, 1103\u20131108. https:\/\/doi.org\/10.1111\/j.1745-7254.2008.00868.x (2008).","journal-title":"Acta Pharmacol. Sin"},{"key":"15863_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1254\/jphs.crj05010x","volume":"100","author":"K Radad","year":"2006","unstructured":"Radad, K., Gille, G., Liu, L. & Rausch, W. D. Use of ginseng in medicine with emphasis on neurodegenerative disorders. J. Pharmacol. Sci. 100, 175\u2013186. https:\/\/doi.org\/10.1254\/jphs.crj05010x (2006).","journal-title":"J. Pharmacol. Sci."},{"key":"15863_CR14","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s11418-011-0609-8","volume":"66","author":"JS Bae","year":"2012","unstructured":"Bae, J. S., Park, H. S., Park, J. W., Li, S. H. & Chun, Y. S. Red ginseng and 20(S)-Rg3 control testosterone-induced prostate hyperplasia by deregulating androgen receptor signaling. J. Nat. Med. 66, 476\u2013485. https:\/\/doi.org\/10.1007\/s11418-011-0609-8 (2012).","journal-title":"J. Nat. Med."},{"key":"15863_CR15","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s11418-010-0504-8","volume":"65","author":"YJ Choi","year":"2011","unstructured":"Choi, Y. J., Choi, H., Cho, C. H. & Park, J. W. Red ginseng deregulates hypoxia-induced genes by dissociating the HIF-1 dimer. J. Nat. Med. 65, 344\u2013352. https:\/\/doi.org\/10.1007\/s11418-010-0504-8 (2011).","journal-title":"J. Nat. Med."},{"key":"15863_CR16","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1248\/bpb.33.468","volume":"33","author":"YS Kwak","year":"2010","unstructured":"Kwak, Y. S., Kyung, J. S., Kim, J. S., Cho, J. Y. & Rhee, M. H. Anti-hyperlipidemic effects of red ginseng acidic polysaccharide from Korean red ginseng. Biol. Pharm. Bull. 33, 468\u2013472. https:\/\/doi.org\/10.1248\/bpb.33.468 (2010).","journal-title":"Biol. Pharm. Bull."},{"key":"15863_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0944-7113(99)80018-X","volume":"6","author":"M Inoue","year":"1999","unstructured":"Inoue, M., Wu, C. Z., Dou, D. Q., Chen, Y. J. & Ogihara, Y. Lipoprotein lipase activation by red ginseng saponins in hyperlipidemia model animals. Phytomedicine 6, 257\u2013265. https:\/\/doi.org\/10.1016\/S0944-7113(99)80018-X (1999).","journal-title":"Phytomedicine"},{"key":"15863_CR18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1142\/S0192415X83000161","volume":"11","author":"M Yamamoto","year":"1983","unstructured":"Yamamoto, M., Uemura, T., Nakama, S., Uemiya, M. & Kumagai, A. Serum HDL-cholesterol-increasing and fatty liver-improving actions of Panax ginseng in high cholesterol diet-fed rats with clinical effect on hyperlipidemia in man. Am. J. Chin. Med. 11, 96\u2013101. https:\/\/doi.org\/10.1142\/S0192415X83000161 (1983).","journal-title":"Am. J. Chin. Med."},{"key":"15863_CR19","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jgr.2019.05.001","volume":"43","author":"YY Lee","year":"2019","unstructured":"Lee, Y. Y. et al. Proteomic studies of putative molecular signatures for biological effects by Korean red ginseng. J. Ginseng Res. 43, 666\u2013675. https:\/\/doi.org\/10.1016\/j.jgr.2019.05.001 (2019).","journal-title":"J. Ginseng Res."},{"key":"15863_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.yrtph.2017.11.007","volume":"92","author":"SJ Park","year":"2018","unstructured":"Park, S. J. et al. Subchronic oral toxicity study of Korean red ginseng extract in Sprague-Dawley rats with a 4-week recovery period. Regul. Toxicol. Pharmacol. 92, 83\u201393. https:\/\/doi.org\/10.1016\/j.yrtph.2017.11.007 (2018).","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"15863_CR21","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jgr.2024.01.002","volume":"48","author":"S Kim","year":"2024","unstructured":"Kim, S. et al. Assessing systemic, developmental, and reproductive toxicity and estrogenicity of Korean red ginseng extract G1899 in juvenile Sprague-Dawley rats. J. Ginseng Res. 48, 333\u2013340. https:\/\/doi.org\/10.1016\/j.jgr.2024.01.002 (2024).","journal-title":"J. Ginseng Res."},{"key":"15863_CR22","doi-asserted-by":"publisher","first-page":"vbac022","DOI":"10.1093\/bioadv\/vbac022","volume":"2","author":"A Kr\u00e4mer","year":"2022","unstructured":"Kr\u00e4mer, A. et al. Mining hidden knowledge: embedding models of cause-effect relationships curated from the biomedical literature. Bioinform Adv. 2, vbac022. https:\/\/doi.org\/10.1093\/bioadv\/vbac022 (2022).","journal-title":"Bioinform Adv."},{"key":"15863_CR23","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2147\/dddt.s450305","volume":"18","author":"BJ Kim","year":"2024","unstructured":"Kim, B. J. et al. Protective effects of red ginseng against tacrine-induced hepatotoxicity: an integrated approach with network Pharmacology and experimental validation. Drug Des. Devel Ther. 18, 549\u2013566. https:\/\/doi.org\/10.2147\/dddt.s450305 (2024).","journal-title":"Drug Des. Devel Ther."},{"key":"15863_CR24","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jgr.2023.02.002","volume":"47","author":"YW Kim","year":"2023","unstructured":"Kim, Y. W. et al. Systemic and molecular analysis dissect the red ginseng induction of apoptosis and autophagy in HCC as mediated with AMPK. J. Ginseng Res. 47, 479\u2013491. https:\/\/doi.org\/10.1016\/j.jgr.2023.02.002 (2023).","journal-title":"J. Ginseng Res."},{"key":"15863_CR25","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jgr.2017.08.006","volume":"43","author":"HH Park","year":"2019","unstructured":"Park, H. H. et al. A formulated red ginseng extract inhibits autophagic flux and sensitizes to doxorubicin-induced cell death. J. Ginseng Res. 43, 86\u201394. https:\/\/doi.org\/10.1016\/j.jgr.2017.08.006 (2019).","journal-title":"J. Ginseng Res."},{"key":"15863_CR26","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/jsfa.4589","volume":"92","author":"YB Song","year":"2012","unstructured":"Song, Y. B. et al. Lipid metabolic effect of Korean red ginseng extract in mice fed on a high-fat diet. J. Sci. Food Agric. 92, 388\u2013396. https:\/\/doi.org\/10.1002\/jsfa.4589 (2012).","journal-title":"J. Sci. Food Agric."},{"key":"15863_CR27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3746\/jkfn.2003.32.1.124","volume":"32","author":"JY Cha","year":"2003","unstructured":"Cha, J. Y., Jun, B. S. & Cho, Y. S. Effect of Korean red ginseng powder on the lipid concentrations and tissue lipid peroxidation in the rats fed high fat diet. J. Korean Soc. Food Sci. Nutr. 32, 124\u2013130 (2003).","journal-title":"J. Korean Soc. Food Sci. Nutr."},{"key":"15863_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/jn\/121.2.165","volume":"121","author":"O Haglund","year":"1991","unstructured":"Haglund, O., Luostarinen, R., Wallin, R., Wibell, L. & Saldeen, T. The effects of fish oil orides, cholesterol, fibrinogen and malondialdehyde in humans supplemented with vitamin E. J. Nutr. 121, 165\u2013169. https:\/\/doi.org\/10.1093\/jn\/121.2.165 (1991).","journal-title":"J. Nutr."},{"key":"15863_CR29","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.freeradbiomed.2021.05.040","volume":"172","author":"C Garcia","year":"2021","unstructured":"Garcia, C. & Blesso, C. N. Antioxidant properties of anthocyanins and their mechanism of action in atherosclerosis. Free Radic Biol. Med. 172, 152\u2013166. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.05.040 (2021).","journal-title":"Free Radic Biol. Med."},{"issue":"4","key":"15863_CR30","doi-asserted-by":"publisher","first-page":"364","DOI":"10.4062\/biomolther.2008.16.4.364","volume":"16","author":"SW Min","year":"2008","unstructured":"Min, S. W., Jung, S. H., Cho, K. H. & Kim, D. H. Antihyperlipidemic effects of red ginseng, crataegii fructus and their main constituents ginsenoside Rg3 and ursolic acid in mice. Biomolecules Ther. 16 (4), 364\u2013369 (2008).","journal-title":"Biomolecules Ther."},{"key":"15863_CR31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/ptr.3250","volume":"25","author":"CM Ahn","year":"2011","unstructured":"Ahn, C. M. et al. Red ginseng extract improves coronary flow reserve and increases absolute numbers of various Circulating angiogenic cells in patients with first ST-segment elevation acute myocardial infarction. Phytother Res. 25, 239\u2013249. https:\/\/doi.org\/10.1002\/ptr.3250 (2011).","journal-title":"Phytother Res."},{"key":"15863_CR32","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ptr.2363","volume":"22","author":"SY Hwang","year":"2008","unstructured":"Hwang, S. Y. et al. Korean red ginseng attenuates hypercholesterolemia-enhanced platelet aggregation through suppression of Diacylglycerol liberation in high-cholesterol-diet-fed rabbits. Phytother Res. 22, 778\u2013783. https:\/\/doi.org\/10.1002\/ptr.2363 (2008).","journal-title":"Phytother Res."},{"key":"15863_CR33","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1074\/jbc.M116.744235","volume":"292","author":"P Lebeau","year":"2017","unstructured":"Lebeau, P. et al. Endoplasmic reticulum stress and Ca2\u2009+\u2009depletion differentially modulate the sterol regulatory protein PCSK9 to control lipid metabolism. J. Biol. Chem. 292, 1510\u20131523. https:\/\/doi.org\/10.1074\/jbc.M116.744235 (2017).","journal-title":"J. Biol. Chem."},{"key":"15863_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair, A. B. & Jacob, S. A simple practice guide for dose conversion between animals and human. J. Basic. Clin. Pharm. 7, 27\u201331. https:\/\/doi.org\/10.4103\/0976-0105.177703 (2016).","journal-title":"J. Basic. Clin. Pharm."},{"key":"15863_CR35","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1080\/09168451.2014.997186","volume":"79","author":"MS Lee","year":"2015","unstructured":"Lee, M. S., Kim, C. T., Kim, I. H. & Kim, Y. Effects of Korean red ginseng extract on hepatic lipid accumulation in HepG2 cells. Biosci. Biotechnol. Biochem. 79, 816\u2013819. https:\/\/doi.org\/10.1080\/09168451.2014.997186 (2015).","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"15863_CR36","doi-asserted-by":"publisher","first-page":"1166898","DOI":"10.3389\/fphar.2023.1166898","volume":"14","author":"W Jin","year":"2023","unstructured":"Jin, W. et al. Hypolipidemic effect and molecular mechanism of ginsenosides: a review based on oxidative stress. Front. Pharmacol. 14, 1166898. https:\/\/doi.org\/10.3389\/fphar.2023.1166898 (2023).","journal-title":"Front. Pharmacol."},{"key":"15863_CR37","doi-asserted-by":"publisher","first-page":"484","DOI":"10.2183\/pjab.86.484","volume":"86","author":"A Endo","year":"2010","unstructured":"Endo, A. A historical perspective on the discovery of Statins. Proc. Jpn Acad. Ser. B Phys. Biol. Sci. 86, 484\u2013493. https:\/\/doi.org\/10.2183\/pjab.86.484 (2010).","journal-title":"Proc. Jpn Acad. Ser. B Phys. Biol. Sci."},{"key":"15863_CR38","doi-asserted-by":"publisher","unstructured":"Lammi, C. et al. Virgin Olive oil extracts reduce oxidative stress and modulate cholesterol metabolism: comparison between oils obtained with traditional and innovative processes. Antioxid. (Basel). 9. https:\/\/doi.org\/10.3390\/antiox9090798 (2020).","DOI":"10.3390\/antiox9090798"},{"key":"15863_CR39","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1021\/np900096w","volume":"72","author":"L Di Donna","year":"2009","unstructured":"Di Donna, L. et al. Statin-like principles of Bergamot fruit (Citrus bergamia): isolation of 3-hydroxymethylglutaryl flavonoid glycosides. J. Nat. Prod. 72, 1352\u20131354. https:\/\/doi.org\/10.1021\/np900096w (2009).","journal-title":"J. Nat. Prod."},{"key":"15863_CR40","doi-asserted-by":"publisher","first-page":"502","DOI":"10.34172\/apb.2020.062","volume":"10","author":"S Sobati","year":"2020","unstructured":"Sobati, S. et al. PCSK9: A key target for the treatment of cardiovascular disease (CVD). Adv. Pharm. Bull. 10, 502\u2013511. https:\/\/doi.org\/10.34172\/apb.2020.062 (2020).","journal-title":"Adv. Pharm. Bull."},{"key":"15863_CR41","doi-asserted-by":"publisher","unstructured":"Seidah, N. G. The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol. Glob. Cardiol. Sci. Pract. e201702, (2017). https:\/\/doi.org\/10.21542\/gcsp.2017.2 (2017).","DOI":"10.21542\/gcsp.2017.2"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15863-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15863-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15863-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T09:10:35Z","timestamp":1757409035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15863-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15863"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-15863-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6525946\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"25 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare the following competing interests: C.H.L., Y.Y.L., S.H.H., and S.H.L. have filed an institution-owned patent entitled \u201cA Composition for Preventing or Treating Dyslipidemia with the Effect of Inhibiting PCSK9 Expression\u201d (Patent No. 10-2023-0194713), related to the development of KRG for hyperlipidemia treatment. No other authors declare any competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of the Korea Ginseng Corporation (Approval Nos. KGC-2015-008, KGC-2023-014, and KGC-2023-020). The experiments were conducted following institutional guidelines and the principles outlined in the ARRIVE 2.0 guidelines to ensure transparency, reproducibility, and adherence to ethical standards in animal research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"30637"}}